Consumption of allium vegetables—which include garlic, leeks, and onions—was linked with a reduced risk of in colorectal cancer in a study of men and women in China published in Asia Pacific Journal of Clinical Oncology.
Consumption of allium vegetables—which include garlic, leeks, and onions—was linked with a reduced risk of in colorectal cancer in a study of men and women in China.
In the Asia Pacific Journal of Clinical Oncology study, 833 patients of colorectal cancer were matched to 833 healthy controls by age, sex and residence area. Demographic and dietary information were collected via face-to-face interviews using a validated food frequency questionnaire. The odds of having colorectal cancer was 79 percent lower in adults who consumed high amounts of allium vegetable compared with those who consumed low amounts.
“It is worth noting that in our research, there seems to be a trend: the greater the amount of allium vegetables, the better the protection,” said senior author Dr. Zhi Li, of the First Hospital of China Medical University. “In general, the present findings shed light on the primary prevention of colorectal cancer through lifestyle intervention, which deserves further in-depth explorations.”
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/full/10.1111/ajco.13133
About Journal
Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
About Wiley
Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company's website can be accessed at www.wiley.com.
Josh Glickman +1 201-748-6572 (US)
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com